bioAffinity Technologies, Inc.
BIAF
$3.84
-$0.16-4.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.75% | -152.45% | -92.43% | -35.61% | -25.02% |
| Total Depreciation and Amortization | -19.47% | -25.05% | -25.08% | 3.34% | 3.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -71.76% | 1,415.67% | 345.28% | 15.12% | -0.17% |
| Change in Net Operating Assets | -56.97% | -686.78% | -81.58% | 165.74% | 141.43% |
| Cash from Operations | -52.61% | -45.11% | -72.75% | 30.02% | -3.77% |
| Capital Expenditure | -- | 138.30% | 52.65% | -22.71% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 138.30% | 52.65% | -22.71% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17.25% | 147.36% | -84.73% | -56.93% | -7.31% |
| Issuance of Common Stock | -33.09% | 325.15% | -- | -54.51% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.84% | -80.65% | -- | -- | -- |
| Cash from Financing | -33.85% | 458.16% | 3,413.72% | -48.89% | 2,489.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -449.70% | 15,461.07% | 121.68% | -79.32% | 120.66% |